In this study, we investigated the function and internal mechanism of CPNE3 in the malignant biological behaviour via RACK1/c‐MET signalling in NSCLC, and explored the feasibility of the MET inhibitor in NSCLC treatment. The gene discussed is MET; the disease is non-small cell lung carcinoma.